Should obese women with polycystic ovary syndrome receive treatment for infertility?

British Medical Journal

Volumn 332, Issue 7539, 2006, Pages 434-435

  Balen, Adam H ^a   Dresner, Martin ^a   Scott, Eleanor M ^a   Drife, James O ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CLOMIFENE CITRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GONADOTROPIN; INSULIN; METFORMIN; STATINE DERIVATIVE;

ANOVULATION; BODY MASS; EDITORIAL; FEMALE; FEMALE INFERTILITY; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MATERNAL MORTALITY; MENSTRUAL CYCLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; THROMBOEMBOLISM; WEIGHT REDUCTION;

FEMALE; HUMANS; INFERTILITY, FEMALE; OBESITY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY, HIGH-RISK; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT REFUSAL; WEIGHT LOSS;

EID: 33644755377     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7539.434     Document Type: Editorial

References (13)

1. Balen AH, Michelmore K. What is polycystic ovary syndrome? Are national views important? Hum Reprod 2002;17:2219-27.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19:41-7 and
3. Fertil Steril 2004;81:19-25.
4. Pasquali R, Antenucci D, Caimirri F, Venturoli S, Paradis R, Fabbri R. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989;68:173-9.
5. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-24.
6. Linné Y. Effects of obesity on women's reproduction and complications during pregnancy. Obesity Rev 2004;5:137-43.
7. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999;94:194-7.
8. Confidential Enquiry into Maternal and Child Health: Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH, 2005.
9. Lewis G, ed. Why mothers die 2000-2002. London: Confidential Enquiry into Maternal and Child Health, 2004.
10. Norman RJ, Noakes M, Wu R, Davies MJ, Moran L, Wang JX. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 2004;10:267-80.
11. National Institute for Clinical Excellence. Fertility assessment and treatment for people with fertility problems. A clinical guideline. London: RCOG Press, 2004.
12. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome Cochrane Database Syst Rev 2003:CD003053.
13. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH. Combined life-style modification and metformin in obese patients with polycystic ovary syndrome (PCOS). A randomised, placebo-controlled, double-blind multi-centre study. Hum Reprod 2006;21:80-9.